Immediate endoscopy or initial Helicobacter pylori serological testing for suspected peptic ulcer disease: Estimating cost-effectiveness using decision analysis

Yale Journal of Biology and Medicine

Volumn 69, Issue 2, 1996, Pages 187-195

  Fendrick, A Mark ^a,b,d   Chernew, Michael E ^b   Hirth, Richard A ^b   Bloom, Bernard S ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; STOMACH SECRETION INHIBITOR;

ARTICLE; BACTERIAL INFECTION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; PEPTIC ULCER; SEROLOGY;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; ENDOSCOPY, GASTROINTESTINAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER; SEROLOGIC TESTS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 0030437541     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Health and Public Policy Committee, American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann. Intern. Med. 102:266-269, 1985.
2. Marshall, B.J. Helicobacter pylori: The etiologic agent for peptic ulcer. JAMA 274:1064-1066, 1995.
3. Walsh, J.H. and Peterson, W.L. Drug therapy: The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N. Engl. J. Med. 33:984-991, 1995.
4. Hentschel, E., Brandstatter, G., Dragoisics, B., Hirschl, A.M., Nemec, H., Schutze, K., Taufer, M., and Wurzer, H. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N. Engl. J. Med. 328:308-312, 1990.
5. Forbes, G.M., Glaser, M.E., Cullen, D.J.E., Warren, J.R., Christiansen, K.J., Marshall, B.J., and Collins, B.J. Duodenal ulcer treated with Helicobacter pylori eradication: Seven-year follow-up. Lancet 343:258-260, 1994.
6. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69, 1994.
7. Fendrick, A.M., Chernew, M.E., Hirth, R.A., and Bloom, B.S. Alternative management strategies for patients with suspected peptic ulcer disease. Ann. Int. Med. 123:260-268, 1995.
8. Talley, N.J., Kost, L., Haddad, A., and Zinsmeister, A.R. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J. Clin. Microbiol. 30:3146-3150, 1992.
9. Cutler, A.F. and Schubert, T.T. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am. J. Gastroenterol. 88:1359-1361, 1993.
10. Van Deventer, G.M., Elashoff, J., Reedy, T., Schneidman, D., and Walsh, J.H. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N. Engl. J. Med. 320:1113-1119, 1989.
11. Rautelin, H., Seppala, K., Renkonen, O.V., Vainio, U., and Kosunen, T.U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob. Agent. Chemother. 36:163-166, 1992.
12. 2-blocker therapy of prompt endoscopy in management of dyspepsia. Lancet 343:811-816, 1994.